Long non-coding RNA BCAR4 regulates osteosarcoma progression by targeting microRNA-1260a

IF 0.8 4区 医学 Q4 ONCOLOGY Bulletin Du Cancer Pub Date : 2025-04-01 DOI:10.1016/j.bulcan.2024.09.003
Yixin Pan , Xiaolei Tang , Yadong Xie , Huamin Zhang , Ziyu Huang , Changjia Huang
{"title":"Long non-coding RNA BCAR4 regulates osteosarcoma progression by targeting microRNA-1260a","authors":"Yixin Pan ,&nbsp;Xiaolei Tang ,&nbsp;Yadong Xie ,&nbsp;Huamin Zhang ,&nbsp;Ziyu Huang ,&nbsp;Changjia Huang","doi":"10.1016/j.bulcan.2024.09.003","DOIUrl":null,"url":null,"abstract":"<div><div>Long non-coding RNAs (lncRNAs) play a crucial role in modulating cancer progression and metastasis. This study investigates the tumor-promoting function of long non-coding RNA BCAR4 in osteosarcoma and elucidates its regulatory mechanism. Although BCAR4 acts as a tumor promoter in osteosarcoma, its regulatory mechanism remains unclear. Bioinformatic analysis revealed a specific interaction between BCAR4 and miR-1260a, with osteosarcoma exhibiting elevated miR-1260a expression inversely correlated with BCAR4 expression. Overexpression of BCAR4 significantly suppressed miR-1260a expression, indicating regulation between BCAR4 and miR-1260a. Luciferase reporter assays confirmed a direct association between miR-1260a and BCAR4 at the sequence level. Silencing of BCAR4 inhibited osteosarcoma cell proliferation and migration while promoting cellular apoptosis, primarily mediated by miR-1260a. Our findings demonstrate that BCAR4 functions as a tumor promotor in osteosarcoma, and that its activity is regulated by miR-1260a. This study also proposes a potential therapeutic approach for treating osteosarcoma by targeting the BCAR4/miR-1260a axis. These different insights shed light on the intricate regulatory network underlying osteosarcoma pathogenesis and offer promising avenues for developing targeted therapies against this aggressive cancer.</div></div>","PeriodicalId":9365,"journal":{"name":"Bulletin Du Cancer","volume":"112 4","pages":"Pages 375-386"},"PeriodicalIF":0.8000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin Du Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0007455124003382","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Long non-coding RNAs (lncRNAs) play a crucial role in modulating cancer progression and metastasis. This study investigates the tumor-promoting function of long non-coding RNA BCAR4 in osteosarcoma and elucidates its regulatory mechanism. Although BCAR4 acts as a tumor promoter in osteosarcoma, its regulatory mechanism remains unclear. Bioinformatic analysis revealed a specific interaction between BCAR4 and miR-1260a, with osteosarcoma exhibiting elevated miR-1260a expression inversely correlated with BCAR4 expression. Overexpression of BCAR4 significantly suppressed miR-1260a expression, indicating regulation between BCAR4 and miR-1260a. Luciferase reporter assays confirmed a direct association between miR-1260a and BCAR4 at the sequence level. Silencing of BCAR4 inhibited osteosarcoma cell proliferation and migration while promoting cellular apoptosis, primarily mediated by miR-1260a. Our findings demonstrate that BCAR4 functions as a tumor promotor in osteosarcoma, and that its activity is regulated by miR-1260a. This study also proposes a potential therapeutic approach for treating osteosarcoma by targeting the BCAR4/miR-1260a axis. These different insights shed light on the intricate regulatory network underlying osteosarcoma pathogenesis and offer promising avenues for developing targeted therapies against this aggressive cancer.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
长非编码RNA BCAR4通过靶向microRNA-1260a调控骨肉瘤的进展
长链非编码rna (lncRNAs)在调节癌症进展和转移中起着至关重要的作用。本研究探讨长链非编码RNA BCAR4在骨肉瘤中的促瘤功能,并阐明其调控机制。虽然BCAR4在骨肉瘤中起肿瘤启动子的作用,但其调控机制尚不清楚。生物信息学分析揭示了BCAR4和miR-1260a之间的特异性相互作用,骨肉瘤中miR-1260a表达升高与BCAR4表达呈负相关。过表达BCAR4可显著抑制miR-1260a的表达,表明BCAR4与miR-1260a之间存在调控作用。荧光素酶报告基因检测证实了miR-1260a与BCAR4在序列水平上的直接关联。BCAR4的沉默抑制骨肉瘤细胞的增殖和迁移,同时促进主要由miR-1260a介导的细胞凋亡。我们的研究结果表明,BCAR4在骨肉瘤中作为肿瘤启动子发挥作用,其活性受miR-1260a调节。本研究提出了一种靶向BCAR4/miR-1260a轴治疗骨肉瘤的潜在治疗方法。这些见解揭示了骨肉瘤发病机制背后复杂的调控网络,并为开发针对这种侵袭性癌症的靶向治疗提供了有希望的途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Bulletin Du Cancer
Bulletin Du Cancer 医学-肿瘤学
CiteScore
1.90
自引率
16.70%
发文量
224
审稿时长
37 days
期刊介绍: Without doubt, the ''Bulletin du Cancer'' is the French language publication of reference in the field of cancerology. Official organ of the French Society of Cancer, this journal covers all the information available, whether in the form of original articles or review articles, but also clinical cases and letters to the editor, including various disciplines as onco-hematology, solids tumors, medical oncology, pharmacology, epidemiology, biology as well as fundamental research in cancerology. The journal proposes a clinical and therapeutic approach of high scientific standard and regular updates in knowledge are thus made possible. Articles can be submitted in French or English.
期刊最新文献
Contents Traitements adjuvants et néoadjuvants du mélanome Vaccins antigéniques dans le mélanome : vers un nouveau paradigme thérapeutique Évolution de la fréquence des cancers en France, mise à jour 2025 Rationnel physiopathologique et prise en charge du syndrome anxio-dépressif parmi les patients atteints de cancers
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1